Nov 29 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
- MAYNE PHARMA AND MITHRA ANNOUNCE TGA APPROVAL OF NEXTSTELLIS® ORAL CONTRACEPTIVE
- MAYNE PHARMA ANTICIPATES COMMERCIAL LAUNCH OF NEXTSTELLIS BY MID-2022 SUPPORTED BY HEALTHCARE PROFESSIONAL MARKET EDUCATION FROM JANUARY 2022
- CONTAINING A NEW CHEMICAL ENTITY (NCE), NEXTSTELLIS WILL RECEIVE 5 YEARS OF MARKET EXCLUSIVITY
Source text: https://bit.ly/3D9n7yU
News: MYX Mithra Pharmaceuticals And Mayne Pharma Announce TGA Approval Of Nextstellis
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.01 |
Change
0.020(0.40%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| $4.98 | $5.03 | $4.98 | $219.2K | 43.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 60 | $5.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.01 | 2421 | 10 |
View Market Depth
| Last trade - 13.53pm 11/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |